OurInsightsTitle

Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

Health technology appraisals of gene therapies appraised through NICE highly specialised technology route. Poster HTA35. Presented at: ISPOR Europe 2024; 17-20 November 2024; Barcelona, Spain.

Register to access the Tolley insights